Cochlear (ASX:COH) - Aktienkurs, Nachrichten und Analyse

COH Aktienübersicht

Cochlear Limited bietet weltweit implantierbare Hörlösungen für Kinder und Erwachsene an.

COH grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	0/6
Künftiges Wachstum	3/6
Vergangene Leistung	5/6
Finanzielle Gesundheit	6/6
Dividenden	0/6

Belohnungen

Prognostiziertes Gewinnwachstum 12.16% pro Jahr

Die Erträge stiegen im vergangenen Jahr um 34%

Risikoanalyse

Bei unseren Risikoprüfungen wurden keine Risiken für COH festgestellt.

Cochlear Limited Wettbewerber

Ramsay Health Care

ASX:RHC

AU$10.9b

Sonic Healthcare

ASX:SHL

AU$12.7b

Austco Healthcare

ASX:AHC

AU$64.9m

Compumedics

ASX:CMP

AU$59.3m

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Cochlear
Historische Aktienkurse
Aktueller Aktienkurs	AU$332.15
52-Wochen-Hoch	AU$350.17
52-Wochen-Tief	AU$220.40
Beta	0.48
11 Monat Veränderung	5.60%
3 Monate Veränderung	-1.59%
1 Jahr Veränderung	45.00%
33 Jahre Veränderung	35.97%
5 Jahre Veränderung	52.24%
Veränderung seit IPO	11,159.32%

Aktuelle Nachrichten und Updates

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Jun 08

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Mar 27

Recent updates

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Oct 04

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Sep 12

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Jun 05

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Apr 05

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Mar 04

Is Cochlear (ASX:COH) A Risky Investment?

Dec 19

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

Nov 16

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Oct 25

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Oct 11

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Aug 23

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Jul 16

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

May 19

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Apr 09

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 04

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Dec 24

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Oct 30

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

Oct 12

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Oct 06

Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Aug 16

Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

Jun 24

A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

May 17

There Are Reasons To Feel Uneasy About Cochlear's (ASX:COH) Returns On Capital

Apr 29

These 4 Measures Indicate That Cochlear (ASX:COH) Is Using Debt Reasonably Well

Mar 20

Insider Buying: The Cochlear Limited (ASX:COH) Independent Non-Executive Director Just Bought 24% More Shares

Mar 02

Cochlear Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Feb 20

Calculating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 11

Our Take On The Returns On Capital At Cochlear (ASX:COH)

Jan 25

Do Institutions Own Cochlear Limited (ASX:COH) Shares?

Jan 07

Introducing Cochlear (ASX:COH), The Stock That Zoomed 107% In The Last Five Years

Dec 21

How Much Is Cochlear Limited (ASX:COH) CEO Getting Paid?

Dec 06

Does Cochlear (ASX:COH) Have A Healthy Balance Sheet?

Nov 18

Aktionärsrenditen

	COH	AU Medical Equipment	AU Markt
7D	2.2%	2.9%	-0.1%
1Y	45.0%	24.5%	8.3%

Rendite im Vergleich zur Industrie: COH übertraf die Branche Australian Medical Equipment , die im vergangenen Jahr eine Rendite von 21.5 erzielte.

Rendite vs. Markt: COH übertraf den Markt Australian, der im vergangenen Jahr eine Rendite von 6.2 erzielte.

Preisvolatilität

Is COH's price volatile compared to industry and market?
COH volatility
COH Average Weekly Movement	3.4%
Medical Equipment Industry Average Movement	9.4%
Market Average Movement	8.3%
10% most volatile stocks in AU Market	16.3%
10% least volatile stocks in AU Market	3.2%

Stabiler Aktienkurs: COH hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: COHDie wöchentliche Volatilität (3%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
1981	4,800	Dig Howitt	www.cochlear.com

Cochlear Limited bietet weltweit implantierbare Hörlösungen für Kinder und Erwachsene an. Das Unternehmen bietet Cochlear-Implantat-Systeme, Soundprozessor-Upgrades, Knochenleitungssysteme, Zubehör und andere Produkte an. Cochlear Limited wurde 1981 gegründet und hat seinen Hauptsitz in Sydney, Australien.

Cochlear Limited's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Cochlear im Vergleich zum Marktanteil des Unternehmens?
COH grundlegende Statistiken
Marktanteil	AU$21.75b
Gewinn(TTM)	AU$350.40m
Umsatz(TTM)	AU$2.15b

62.1x

Kurs-Gewinn-Verhältnis

10.1x

Kurs-Umsatz-Verhältnis

Ist COH zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
COH Gewinn- und Verlustrechnung (TTM)
Einnahmen	AU$2.15b
Kosten der Einnahmen	AU$546.90m
Bruttogewinn	AU$1.60b
Sonstige Ausgaben	AU$1.25b
Umsatz	AU$350.40m

Zuletzt gemeldete Gewinne

Dec 31, 2023

Datum des nächsten Gewinnberichts

Aug 15, 2024

Gewinn per Aktie (EPS)	5.35
Bruttomarge	74.56%
Nettogewinnspanne	16.30%
Schulden/Eigenkapital-Verhältnis	0%

Wie hat sich COH auf lange Sicht entwickelt?

Historische Performance und Vergleiche

Dividenden

1.2%

Aktuelle Dividendenrendite

70%

Ausschüttungsquote

COH Aktienübersicht

Belohnungen

Risikoanalyse

Cochlear Limited Wettbewerber

ASX:RHC

AU$10.9b

ASX:SHL

AU$12.7b

ASX:AHC

AU$64.9m

ASX:CMP

AU$59.3m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Upcoming dividend of AU$2.00 per share

Recent updates

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Upcoming dividend of AU$2.00 per share

First half dividend increased to AU$2.00

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

First half 2024 earnings: EPS in line with expectations, revenues disappoint

Price target increased by 7.0% to AU$272

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$1.55 per share at 1.3% yield

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Is Cochlear (ASX:COH) A Risky Investment?

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Key Executive recently bought AU$97k worth of stock

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Upcoming dividend of AU$1.45 per share

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Full year 2022 earnings: EPS misses analyst expectations

Cochlear Announces Final Dividend Payable on 17 October 2022

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Upcoming dividend of AU$1.55 per share

Investor sentiment improved over the past week

First half 2022 earnings: EPS and revenues exceed analyst expectations

Cochlear Limited Announces Interim Dividend Expected to Be Payable on 21 April 2022

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

FDA Approves Cochlear Nucleus Implants for Unilateral Hearing Loss/Single-Sided Deafness

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Independent Non-Executive Director recently bought AU$56k worth of stock

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited Advises of US Patent Infringement Complaint

Upcoming dividend of AU$1.40 per share

CEO, MD exercised options and sold AU$295k worth of stock

Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservation in Combination with Cochlear Implantation

Independent Non-Executive Director recently bought AU$94k worth of stock

Independent Chairman Roderic Holliday-Smith has left the company

Erträge & Einnahmen